Phibro Animal Health Corp
Phibro Animal Health Corp (PAHC) Covered Calls
As of September 24, 2026, PAHC has 10 covered call opportunities in the coming three months. Return ranges from 4.2 to 48.0% until expiration. Annualized return ranges from 27.3 to 205.9%. The nearest expiration is October 16, 2026. Maximum potential profit is $1,627.
Read more
Running PAHC covered calls helps you generate consistent income from Phibro Animal Health Corp's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Phibro Animal Health Corp involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best PAHC covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if PAHC stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling PAHC covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Phibro Animal Health Corp covered call is worth writing.
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture.
In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.
Income-focused investors, long-term PAHC holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling PAHC covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Phibro Animal Health Corp covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryDrug Manufacturers - Specialty & Generic
- SectorHealthcare
- IV percentile82.94% Elevated
- Market cap (M$)1,399
- 52 weeks high-42.66%
- 52 weeks low21.95%
- Analyst recommendationHold
2.80 - Target price$44.00
27.72% above the current stock price - Dividend—
- Payout ratio19.72%
- Earnings date2026-11-04
- P/E14.15
- Future P/E8.95
- EPS (ttm)2.43
- EPS growth next 5 years8.87%
As of September 24, 2026
| 2026-12-18 | 85 | 50.00 | 47.36 | 0.20 | 0.60 | 1627.00 | 47.95 | 205.91 | -0.59 | +0.10 | 1 | 0.40 |
| 2026-11-20 | 57 | 40.00 | 17.89 | 0.05 | 2.60 | 612.00 | 18.04 | 115.50 | -0.15 | +0.29 | 12 | 2.55 |
| 2027-03-19 | 176 | 50.00 | 47.36 | 0.05 | 2.75 | 1612.00 | 47.51 | 98.53 | -0.15 | +0.22 | 0 | 2.70 |
| 2026-12-18 | 85 | 40.00 | 17.89 | 0.50 | 3.30 | 657.00 | 19.36 | 83.15 | -1.47 | +0.34 | 35 | 2.80 |
| 2026-10-16 | 22 | 35.00 | 3.15 | 0.35 | 2.10 | 142.00 | 4.19 | 69.43 | -1.03 | +0.43 | 304 | 1.75 |
| 2027-03-19 | 176 | 45.00 | 32.63 | 0.10 | 3.50 | 1117.00 | 32.92 | 68.27 | -0.29 | +0.29 | 0 | 3.40 |
| 2026-11-20 | 57 | 35.00 | 3.15 | 1.65 | 3.60 | 272.00 | 8.02 | 51.33 | -4.86 | +0.50 | 2 | 1.95 |
| 2027-03-19 | 176 | 40.00 | 17.89 | 1.40 | 4.00 | 747.00 | 22.02 | 45.66 | -4.13 | +0.40 | 1 | 2.60 |
| 2026-12-18 | 85 | 35.00 | 3.15 | 1.90 | 4.40 | 297.00 | 8.75 | 37.59 | -5.60 | +0.52 | 2 | 2.50 |
| 2027-03-19 | 176 | 35.00 | 3.15 | 3.40 | 6.10 | 447.00 | 13.17 | 27.32 | -10.02 | +0.56 | 11 | 2.70 |
As of September 24, 2026
Sell covered calls with the data behind you
Find the best PAHC covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→